Panacea Index Logo

Command Palette

Search for a command to run...

Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial.

The Journal of clinical endocrinology and metabolism
December 1, 2019
Fredrik Rosqvist et al. (19 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine how saturated fatty acids (SFA) and polyunsaturated fatty acids (PUFA) affect liver fat accumulation and ceramide levels in overweight and obese individuals.

Results Summary

SFA increased liver fat content and serum ceramides, while PUFA prevented liver fat accumulation and reduced ceramides. The adverse metabolic effects of SFA were reversed by calorie restriction.

Population

Overweight or obese men and women (n = 61).

Effective Dosage

Not specified (muffins high in palm oil [SFA] or sunflower oil [PUFA] added to habitual diet).

Duration

8 weeks of overfeeding, followed by 4 weeks of caloric restriction.

Interactions

None mentioned

Extracted Claims (15)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Saturated fatty acid (SFA)-enriched diet (overfeeding)
increase
liver fat content
overweight and obese humans
50% relative increase
markedly induced
#1
Saturated fatty acid (SFA)-enriched diet (overfeeding)
increase
liver enzymes
overweight and obese humans
-
induced
#2
Saturated fatty acid (SFA)-enriched diet (overfeeding)
increase
atherogenic serum lipids
overweight and obese humans
-
induced
#3
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding)
no change
liver fat
overweight and obese humans
-
did not increase
#4
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding)
no change
liver enzymes
overweight and obese humans
-
did not increase
#5
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding)
no change
blood lipids
overweight and obese humans
-
did not cause any adverse effects on
#6
Saturated fatty acid (SFA)-enriched diet (overfeeding)
no change
visceral fat
overweight and obese humans
-
had no differential effect on the accumulation of
#7
Saturated fatty acid (SFA)-enriched diet (overfeeding)
no change
pancreas fat
overweight and obese humans
-
had no differential effect on the accumulation of
#8
Saturated fatty acid (SFA)-enriched diet (overfeeding)
no change
total body fat
overweight and obese humans
-
had no differential effect on the accumulation of
#9
Saturated fatty acid (SFA)-enriched diet (overfeeding)
increase
circulating ceramides
overweight and obese humans
-
increased
#10
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding)
decrease
circulating ceramides
overweight and obese humans
-
reduced
#11
Calorie restriction
decrease
adverse metabolic effects of SFA
overweight and obese humans
-
reversed
#12
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding)
decrease
liver fat accumulation
overweight individuals
-
prevents
#13
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding)
decrease
ceramides
overweight individuals
-
reduces
#14
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding)
decrease
hyperlipidemia
overweight individuals
-
reduces
#15
Abstract

CONTEXT: Saturated fatty acid (SFA) vs polyunsaturated fatty acid (PUFA) may promote nonalcoholic fatty liver disease by yet unclear mechanisms. OBJECTIVE: To investigate if overeating SFA- and PUFA-enriched diets lead to differential liver fat accumulation in overweight and obese humans. DESIGN: Double-blind randomized trial (LIPOGAIN-2). Overfeeding SFA vs PUFA for 8 weeks, followed by 4 weeks of caloric restriction. SETTING: General community. PARTICIPANTS: Men and women who are overweight or have obesity (n = 61). INTERVENTION: Muffins, high in either palm (SFA) or sunflower oil (PUFA), were added to the habitual diet. MAIN OUTCOME MEASURES: Lean tissue mass (not reported here). Secondary and exploratory outcomes included liver and ectopic fat depots. RESULTS: By design, body weight gain was similar in SFA (2.31 ± 1.38 kg) and PUFA (2.01 ± 1.90 kg) groups, P = 0.50. SFA markedly induced liver fat content (50% relative increase) along with liver enzymes and atherogenic serum lipids. In contrast, despite similar weight gain, PUFA did not increase liver fat or liver enzymes or cause any adverse effects on blood lipids. SFA had no differential effect on the accumulation of visceral fat, pancreas fat, or total body fat compared with PUFA. SFA consistently increased, whereas PUFA reduced circulating ceramides, changes that were moderately associated with liver fat changes and proposed markers of hepatic lipogenesis. The adverse metabolic effects of SFA were reversed by calorie restriction. CONCLUSIONS: SFA markedly induces liver fat and serum ceramides, whereas dietary PUFA prevents liver fat accumulation and reduces ceramides and hyperlipidemia during excess energy intake and weight gain in overweight individuals.

Medical Subject Headings (MeSH)
AdultCeramidesDietary FatsDouble-Blind MethodFatty Acids, UnsaturatedFatty LiverFemaleFollow-Up StudiesHumansHyperphagiaLipidsMaleObesityOverweightPrognosisWeight Gain
Study Links
Quality Scores
Safety70
Efficacy85/10
Quality90/10
Citation Metrics
Total Citations158
Citations/Year26.3
Relative Citation Ratio8.23
NIH Percentile97%
Research Impact Scores
APT Score0.95
Weight Score2.83
Normalized Score0.80
Related Supplements